Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
CDX Models

CDX Models

Cell line-derived xenograft (CDX) models are among the most commonly used research models for efficacy evaluation of anti-cancer therapies. CDX models created by implanting cancer cell lines into immunodeficient mice have contributed largely to the development of cancer drug therapies. The establishment of CDX models involves inoculation of tumor cells (including various types of cancer cells) into immunodeficient mice.

After high-throughput drug screening in vitro, the CDX model is then used for in vivo drug infusion and efficacy evaluations. Due to the long-term cell passage in vitro, they have the characteristics of high homology, easy construction, and reproducibility. However, cell lines often lose their original biological characteristics through many passages. CDXs can be complementary to tumor biopsies and PDXs. CDXs offer an opportunity to generate models for those patients that cannot undergo surgery or an alternative invasive procedure.

Download
medicilon icon-diamond.pngModel Type
Cancer TypeCell Lines
Brain cancerU-87 MG, LN-229, SH-SY5Y
Breast cancerBT474, HCC1569, HCC1954, HCC70, JIMT-1, MCF7, MDA-MB-231, MDA-MB-468, MX-1, SUM149PT, ZR-75-1
Colon cancerCOLO 205, DLD-1, HCT-116, HCT-15, HT-29, LIM-1215, LoVo, Ls174T, NCI-H580, RKO, SW480, SW620
EndometriumAN3 CA, HEC-1-A
FibrosarcomaHT-1080
Gastric cancerHs 746T, MKN-45, NCI-N87, SNU-16
Head and neck cancerTT, FaDu
LeukemiaCCRF-CEM, HEL, HL-60, K-562, MV-4-11, THP-1
Liver cancerHep G2, HuH-7
Lung cancerA549, Calu-1, Calu-3, Calu-6, HCC827, MOTO-211H, NCI-H1299, NCI-H1650, NCI-H1975, NCI-H2122, NCI-H358, NCI-H460, NCI-H520, NCI-H2228, NCI-H526, NCI-H69, NCI-H727, PC9, A427
LymphomaSU-DHL-4, DB, SU-DHL-6, Mino, Daudi, JeKo-1, Raji, TMD-8, WSU DLCL2, DOHH2, OCI-LY19, OCI-HL10, MOLM13, U-937
MelanomaA375
MyelomaMM.1S, NCI-H929, RPMI-8226
OsteosarcomaSJSA-1
Ovarian cancerA2780, OVCAR-3, SK-OV-3
Pancreatic cancerAsPC-1, Bx PC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II, Mia PaCa-2, PANC-1, SU.86.86
Prostate cancerDU145, PC-3
Renal cancer786-O, OS-RC-2, A498
Skin cancerA-431
Relevant articles